NFKB1 and carcinoma of esophagus: In oesophageal cancer, neoadjuvant chemotherapy activated T cells, including Tfh cells, which stimulate CD40 on B cells to promote their activation and anti‐tumour effects via NF‐κB signalling and antigen presentation.31